Neoplastic and Nonneoplastic Liver Lesions Induced by Dimethylnitrosamine in Japanese Medaka Fish

Veterinary Pathology

Volumn 49, Issue 2, 2012, Pages 372-385

  Hobbie, K R ^a   DeAngelo, A B ^b   George, M H ^b   Law, J M ^c  

^a INTEGRATED LABORATORY SYSTEMS   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

alternative animal models; aquatic animal models; comparative carcinogenesis; dimethylnitrosamine; hepatocarcinogenesis; Japanese medaka; Oryzias latipes

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN; DIMETHYLNITROSAMINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ANIMAL DISEASE; ARTICLE; BILIARY TRACT TUMOR; CARCINOGEN TESTING; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; FEMALE; FISH DISEASE; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MUTAGEN TESTING; ORYZIAS; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; TOXIC HEPATITIS; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BILIARY TRACT NEOPLASMS; BIOLOGICAL MARKERS; CARCINOGENICITY TESTS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DIMETHYLNITROSAMINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; FEMALE; FISH DISEASES; LIVER; LIVER NEOPLASMS; MALE; MUTAGENICITY TESTS; ORYZIAS; RATS; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; MAMMALIA; ORYZIAS; ORYZIAS LATIPES; ORYZIINAE; RATTUS;

EID: 84857680063     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985811409443     Document Type: Article

References (46)

1. Bailey GS,Williams DE,Hendricks JD.Fish models for environmental carcinogenesis: the rainbow trout.Environ Health Perspect. 1996;104 (suppl 1): 5-21.
2. Bissell DM,Roulot D,George J.Transforming growth factor β and the liver.Hepatology. 2001;34:859-867.
3. Boorman GA,Botts S,Bunton TE, et al.Diagnostic criteria for degenerative, inflammatory, proliferative nonneoplastic and neoplastic liver lesions in medaka (Oryzias latipes): consensus of a National Toxicology Program pathology working group.Toxicol Pathol. 1997;25:202-210.
4. Bunton TE.Expression of actin and desmin in experimentally induced hepatic lesions and neoplasms from medaka (Oryzias latipes).Carcinogenesis. 1995;16:1059-1063.
5. Calabrese F,Valente M,Giacometti C, et al.Parenchymal transforming growth factor beta-1: its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology.J Gastroenterol Hepatol. 2003;18:1302-1308.
6. Cutroneo KR,White SL,Chiu J-F,Ehrlich HP.Tissue fibrosis and carcinogenesis: divergent or successive pathways dictate multiple molecular therapeutic targets for oligo decoy therapies.J Cell Biochem. 2006;97:1161-1174.
7. De Gouville A-C,Boullay V,Krysa G, et al.Inhibition of TGF-β signaling by an ALK 5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis.Br J Pharmacol. 2005;145:166-177.
8. Dick A,Mayr T,Hermann B,Meier A,Hammerschmidt M.Cloning and characterization of zebrafish smad2, smad3 and smad4.Gene. 2000;246:69-80.
9. Elliot EL,Blobe GC.Role of transforming growth factor beta in human cancer.J Clin Oncol. 2005;23:2078-2093.
10. Flanders KC.Smad3 as a mediator of the fibrotic response.Int J Exp Path. 2004;85:47-64.
11. Friedman SL.Molecular regulation of hepatic fibrosis, an integrated cellular response to injury.J Biol Chem. 2000;275:2247-2250.
12. George J.Mineral metabolism in dimethylnitrosamine-induced hepatic fibrosis.Clin Biochem. 2006;39:984-991.
13. George J,Tsutsumi M,Takase S.Expression of hyaluronic acid in N-nitrosodimethylamine induced hepatic fibrosis in rats.Int J Biochem Cell Biol. 2004;36:307-319.
14. Grieco MP,Hendricks JD,Scanian RA,Sinnhuber RO,Pierce DA.Carcinogenicity and acute toxicity of dimethylnitrosamine in rainbow trout (Salmo gairdneri).J Natl Cancer Inst. 1978;60:1127-1131.
15. Hardman RC,Volz DC,Kullman SW,Hinton DE.An in vivo look at vertebrate liver architecture: three-dimensional reconstructions from medaka (Oryzias latipes).Anat Rec. 2007;290:770-782.
16. Harms CA,Kennedy-Stoskopf S,Horne WA,Fuller FJ,Tompkins WAF.Cloning and sequencing hybrid striped bass (Morone saxatilis x M. chrysops) transforming growth factor-β (TGF-β), and development of a reverse transcription quantitative competitive polymerase chain reaction (RT-qcPCR) assay to measure TGF-β mRNA of teleost fish.Fish Shellfish Immunol. 2000;10:61-85.
17. Hata J,Ikeda E,Uno H,Asano S.Expression of hepatocyte growth factor mRNA in rat liver cirrhosis induced by N-nitrosodimethylamine as evidenced by in situ RT-PCR.J Histochem Cytochem. 2002;50:1461-1468.
18. Hawkins WE,Walker WW,Fournie JW,Manning CS,Krol RM. Use of the Japanese medaka (Oryzias latipes) and Guppy (Poecilia reticulata) in carcinogenesis testing under National Toxicology Program protocols.Toxicol Pathol. 2003;31 (suppl 1): 88-91.
19. He J-Y,Ge W-H,Chen Y.Iron deposition and fat accumulation in dimethylnitrosamine-induced liver fibrosis in rat.World J Gastroenterol. 2007;13:2061-2065.
20. Hinton DE,Segner H,Braunbeck T.Toxic responses of the liverTarget Organ Toxicity in Marine and Freshwater Teleosts. 1st ed. Schlenk DBenson WH, ed. New York, NY: Taylor & Francis; 2001:224-261.
21. Hobbie KR,Deangelo AB,King LC,Winn RN,Law JM.Toward a molecular equivalent dose: use of the medaka model in comparative risk assessment.Comp Biochem Physiol C Toxicol Pharmacol. 2009;149:141-151.
22. Jin Y-L,Enzan H,Kuroda N, et al.Tissue remodeling following submassive hemorrhagic necrosis in rat livers induced by an intraperitoneal injection of dimethylnitrosamine.Virchows Arch. 2003;442:39-47.
23. Kang JS,Morimura K,Salim EI,Wanibuchi H,Yamaguchi S,Fukushima S.Persistence of liver cirrhosis in association with proliferation of nonparenchymal cells and altered location of α-smooth muscle actin-positive cells.Toxicol Pathol. 2005;33:329-335.
24. Khudoley VV.Use of aquarium fish.Danio rerio and Poecilia reticulata, as test species for evaluation of nitrosamine carcinogenicity. J Natl Cancer Inst. 1984;65:65-70.
25. Laurén DJ,The SJ,Hinton DE.Cytotoxicity phase of diethylnitrosamine-induced hepatic neoplasia in medaka.Cancer Res. 1990;50:5504-5514.
26. Law JM.Mechanistic considerations in small fish carcinogenicity testing.ILAR J. 2001;42:274-284.
27. Law JM.Issues related to the use of fish models in toxicologic pathology: session introduction.Toxicol Pathol. 2003;31 (suppl): 49-52.
28. Lim Y-S,Kim K-A,Jung J-O, et al.Modulation of cytokeratin expression during in vitro cultivation of human hepatic stellate cells: evidence of transdifferentiation from epithelial to mesenchymal phenotype.Histochem Cell Biol. 2002;118:127-136.
29. Lowes KN,Croager EJ,Olynyk JK,Abraham LJ,Yeoh GCT.Oval cell-mediated liver regeneration: role of cytokines and growth factors.J Gasteroenterol Hepatol. 2003;18:4-12.
30. Matsuura I,Denissova NG,Wang G,He D,Long J,Liu F.Cyclin-dependent kinases regulate the antiproliferative function of Smads.Nature. 2004;430:226-231.
31. Mizgireuv IV,Majorova IG,Gorodinskaya VM,Khudoley VV,Revskoy SY.Carcinogenic effect of N-nitrosodimethylamine on diploid and triploid zebrafish (Danio rerio).Toxicol Pathol. 2004;32:514-518.
32. Nguyen LN,Furuya MH,Wolfraim LA, et al.Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation.Hepatology. 2007;45:31-41.
33. Okihiro MS,Hinton DE.Progression of hepatic neoplasia in medaka (Oryzias latipes) exposed to diethylnitrosamine.Carcinogenesis. 1999;20:933-940.
34. Okihiro MS,Hinton DE.Partial hepatectomy and bile duct ligation in rainbow trout (Oncorhynchus mykiss): histologic, immunohistochemical and enzyme histochemical characterization of hepatic regeneration and biliary hyperplasia.Toxicol Pathol. 2000;28:342-356.
35. Peto R,Gray R,Brantom P,Grasso P.Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study.Cancer Res. 1991;51:6415-6451.
36. Popov Y,Patsenker E,Fickert P,Trauner M,Schuppan D.Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes.J Hepatol. 2005;43:1045-1054.
37. Roberts AB,Tian F,DaCosta Byfield S, et al.Smad3 is key to TGF-β-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis.Cytokine Growth Factor Rev. 2006;17:19-27.
38. Rossmanith W,Schulte-Hermann R.Biology of transforming growth factor β in hepatocarcinogenesis.Microsc Res Tech. 2001;52:430-436.
39. Sato Y,Harada K,Ozaki S, et al.Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat.Am J Pathol. 2007;171:1859-1871.
40. Sell S.Cellular origin of hepatocellular carcinomas.Cell Dev Biol. 2002;13:419-424.
41. Senda T,Nomura R.The expression of cytokeratin in hepatic stellate cells of the cod.Arch Histol Cytol. 2003;66:437-444.
42. Song S-L,Gong Z-J,Zhang Q-R,Huang T-X.Effects of Chinese traditional compound, JinSanE, on expression of TGF-β1 and TGF-β1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.World J Gasterenterol. 2005;11:2269-2276.
43. Souliotis VL,Chhabra S,Anderson LM,Kyrtopoulos SA.Dosimetry of O6-methylguanine in rat DNA after low-dose, chronic exposure to N-nitrosodimethylamine (NDMA): implications for the mechanism of NDMA hepatocarcinogenesis.Carcinogenesis. 1995;16:2381-2387.
44. Tao L-H,Enzan H,Hayashi Y, et al.Appearance of denuded hepatic stellate cells and their subsequent myofibroblasts-like transformation during the early stage of biliary fibrosis in the rat.Med Electron Microsc. 2000;33:217-230.
45. Thorgeirsson SS,Grisham JW.Molecular pathogenesis of human hepatocellular carcinoma.Nat Genet. 2002;31:339-346.
46. Wolf JC,Wolfe MJ.A brief overview of nonneoplastic hepatic toxicity in fish.Toxicol Pathol. 2005;33:75-85.